Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 (To Pur Com)股价重挫19.14% 市值跌662.89万美元

市场透视11-06

北京时间2024年11月06日00时47分，Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 (To Pur Com)（LIXTW.us）股票出现异动，股价急速下跌19.14%。截至发稿，该股报0.021美元/股，成交量3200股，换手率0.00%，振幅1.17%。最近的财报数据显示，该股实现营业收入--，净利润--，每股收益--，毛利--，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2481870866?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-06 00:47","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2481870866","market":"us","top_or_hot":-1,"title":"Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)股价重挫19.14% 市值跌662.89万美元","media":"市场透视","content":"<div>\n<p>北京时间2024年11月06日00时47分，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)（LIXTW.us）股票出现异动，股价急速下跌19.14%。截至发稿，该股报0.021美元/股，成交量3200股，换手率0.00%，振幅1.17%。最近的财报数据显示，该股实现营业收入--，净利润--，每股收益--，毛利--，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110600470195bdd357&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)股价重挫19.14% 市值跌662.89万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)股价重挫19.14% 市值跌662.89万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-06 00:47 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110600470195bdd357&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年11月06日00时47分，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)（LIXTW.us）股票出现异动，股价急速下跌19.14%。截至发稿，该股报0.021美元/股，成交量3200股，换手率0.00%，振幅1.17%。最近的财报数据显示，该股实现营业收入--，净利润--，每股收益--，毛利--，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110600470195bdd357&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110600470195bdd357&s=b","article_id":"2481870866","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110600470195bdd357&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2481870866","pubTimestamp":1730825221,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年11月06日00时47分，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票出现异动，股价急速下跌19.14%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票所在的生物技术行业中，整体涨幅为1.11%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一种名为蛋白磷酸酶 2A 抑制剂的药物来改善患者的生活。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","LIXT":"Lixte Biotechnology Holdings Inc.","LIXTW":"Lixte Biotechnology Holdings Inc. Warrant"},"translate_title":"Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 (To Pur Com) The stock price plummeted 19.14% and the market value fell by US $6.6289 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LIXT":1,"LIXTW":0.9},"content_text":"北京时间2024年11月06日00时47分，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)（LIXTW.us）股票出现异动，股价急速下跌19.14%。截至发稿，该股报0.021美元/股，成交量3200股，换手率0.00%，振幅1.17%。最近的财报数据显示，该股实现营业收入--，净利润--，每股收益--，毛利--，市盈率-0.15倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)股票所在的生物技术行业中，整体涨幅为1.11%。其相关个股中，Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Nutriband Inc C/Wts (To Pur Com)涨幅较大，Zyversa Therapeutics, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Elevai Labs, Inc.较为活跃，换手率分别为5432.46%、2028.00%、748.87%，振幅较大的相关个股有Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)，振幅分别为91.40%、56.04%、45.39%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一种名为蛋白磷酸酶 2A 抑制剂的药物来改善患者的生活。其产品线专注于蛋白磷酸酶 2A 抑制剂，与细胞毒剂和/或 X 射线、免疫检查点阻断剂和其他癌症疗法联合使用。该公司相信蛋白磷酸酶抑制剂对多种癌症具有治疗潜力。 它专注于特定蛋白磷酸酶抑制剂（称为LB-100）的临床开发，该抑制剂已被证明在产生很少或不产生毒性的剂量下具有临床抗癌活性。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481870866"}